Financials

Discussions Seasonals

SVNS fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to SOLVONIS THERAPEUTICS PLC ORD GBP0.001 operating, investing, and financing activities

SVNS free cash flow for H1 24 is -427 k GBP. For 2023, SVNS free cash flow was -1.47 M GBP and operating cash flow was -1.24 M GBP.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: GBP

TTM

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—